| 英文别名 |
Yohimbine hydrochloride;17-Hydroxy-yohimban-16-carboxylic acid methyl ester hydrochloride;Yohimbe HCl;Yohimbine (Hydrochloride);YOHIMBINE HCL(P);YOHIMBINE HCL(RG);YOHIMBINE HCL(RG) PrintBack;Yohimbine Hydrochlor;Yohimbine Hydrochloride Standard;Yohimbine HCl;Antagonil;Yohimbe;Aphrodine hydrochloride;Yohimbine monohydrochloride;Yohimbin hydrochloride [USP];NB2E1YP49F;Thybine;Aphrodyne;AK208923;Yohimbine hydrochloride, 99%;YOHIMBINE CHLORIDE;Yohimbin HCl;CHE;methyl (1S,15R,18S,19R,20S)-18-hydroxy-3,13-diazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4,6,8-tetraene-19-carboxylate hydrochloride;YOHIMBINE HYDROCHLORIDE [EP MONOGRAPH];EU-0101210;D06671;NSC19509;NCGC00094457-01;Menolysin;LP01210;YOHIMBINE HYDROCHLORIDE [MI];AS-13939;AI3-60247;17-Hydroxyyohimban-16-carboxylic acid methyl ester hydrochloride;MLS001333983;17?-Hydroxyyohimban-16?-carboxylic acid methyl ester hydrochloride;Yohimbine hydrochloride, >=98% (TLC), powder;Yohimban-16alpha-carboxylic acid, 17alpha-hydroxy-, methyl ester, monohydrochloride;Q15680050;Yobinol;Tosanpin;HMS1569F10;Yohimbine hydrochloride, European Pharmacopoeia (EP) Reference Standard;AKOS015951349;17.ALPHA.-HYDROXY-20-.ALPHA.-YOHIMBAN-16-.BETA.-CARBOXYLIC ACID, METHYL ESTER, HYDROCHLORIDE;Prestwick_961;Yohimbine-Hydrochloride;Gynimbine;NSC 19509;s2373;YOHIMBINE HYDROCHLORIDE [MART.];Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, hydrochloride (1:1), (16alpha,17alpha)-;SMR000058527;Yohydrol;17alpha-Hydroxy-20-alpha-yohimban-16-beta-carboxylic acid, methyl ester, hydrochloride;Y 3125;Yohimbin hydrochloride;methyl(1S,15R,18S,19R,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate;hydrochloride;DTXSID40891272;NSC-19509;Yohimbine hydrochloride (Antagonil);Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, monohydrochloride, (16alpha,17alpha)-;Yohimbine hydrochloride, analytical standard;Parkimbine;YOHIMBINE HYDROCHLORIDE [VANDF];SR-01000597896;YOHIMBINE HYDROCHLORIDE [WHO-DD];BCP19708;SR-01000597896-4;SR-01000597896-1;Yohimbine hydrochloride [USP:BAN];YOHIMBINE HYDROCHLORIDE [USP-RS];Tox21_501210;NCGC00261895-01;SR-01000075297-1;HY-N0127;YOHIMBINE HYDROCHLORIDE [USP MONOGRAPH];Dayto-Himbin;Yohimban-16-alpha-carboxylic acid, 17-alpha-hydroxy-, methyl ester, hydrochloride;65-19-0 (HCL);Yohimbine hydrochloride, United States Pharmacopeia (USP) Reference Standard;CCG-208327;65-19-0;Q-201938;SW199050-2;Y0002;UNII-NB2E1YP49F;SR-01000075297;YOHIMBINE HYDROCHLORIDE [GREEN BOOK];yohimbinhydrochlorid-;CHEMBL537669;Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, monohydrochloride, (16.alpha.,17.alpha.)-;EINECS 200-600-4;AC-22571;CS-5238;NIH 9689;Yohimbine hydrochloride (USP);MLS001306411;LS-162742;Yohimbin hydrochloride (USP);YOHIMBINE HYDROCHLORIDE (MART.);DTXCID601030458;Yohimbine hydrochloride (USP:BAN);MFCD00012674;YOHIMBINE HYDROCHLORIDE (US... |
